Buy Symbicort (Budesonide / Formoterol) — Online Prescription

Symbicort is a prescription inhaler for asthma (ages 6 and older) and for COPD maintenance (chronic bronchitis and emphysema). It combines budesonide, an inhaled steroid that reduces airway inflammation, with formoterol, a bronchodilator that starts working within minutes and lasts about 12 hours. On the FDA label it is a twice-daily controller; asthma guidelines also use it as a reliever in "SMART" plans set up by your prescriber.

Only as part of a SMART (single maintenance and reliever therapy) plan your prescriber sets up. Because formoterol starts working within minutes, US (NAEPP 2020) and international (GINA) asthma guidelines recommend budesonide/formoterol as both the daily controller and the as-needed reliever for many people with moderate-to-severe asthma. The total is capped at 12 puffs a day for ages 12 and older and 8 puffs a day for ages 4 to 11. This reliever use is guideline-recommended but not on the US FDA label, so follow the written plan you get from your prescriber — and don't use it as a reliever for COPD unless told to.

Yes. On a standard plan, you take Symbicort twice daily as a controller and keep albuterol as your rescue inhaler. On a SMART plan, Symbicort itself is usually the reliever and albuterol may not be needed — your prescriber decides. Either way, needing extra puffs more often than usual is a sign to call your prescriber.

Budesonide and formoterol fumarate dihydrate inhalation aerosol, in the same 80/4.5 and 160/4.5 strengths. Breyna (Viatris with Kindeva) was the first FDA-approved generic, approved in March 2022 and launched in 2023; an unbranded budesonide/formoterol generic is also sold. Generics cost pharmacies only modestly less than brand, so with the manufacturer's $35 cap, brand Symbicort is often cheaper for insured patients.

Yes — Breyna is an FDA-approved generic of Symbicort with the same two medicines (budesonide and formoterol) in the same 80/4.5 and 160/4.5 strengths and the same dosing. The inhaler looks different; use it the same way (shake, 2 puffs twice daily, rinse and spit).

The first number is the budesonide (steroid) dose per puff; the formoterol dose is the same (4.5 mcg) in both. 80/4.5 is the lower steroid dose and the only strength for children 6 to 11; 160/4.5 is the higher dose for more persistent asthma in ages 12 and older and the strength used for COPD. The maximum labeled dose is 2 puffs of 160/4.5 twice daily.

In the FDA trials, a meaningful bronchodilator effect started within 15 minutes of a dose, peaked within 3 hours and lasted about 12 hours. Full control of asthma can take 2 weeks or longer; if you're not controlled after 1–2 weeks on 80/4.5, your prescriber may move you to 160/4.5.

It was reported slightly more often than with placebo in the asthma trials — 3.2% on Symbicort 80/4.5 versus 0.8% on placebo — so it's a recognized but uncommon side effect. Tell your prescriber if it's persistent. The most common side effects were colds and sore throat, headache, upper respiratory infections, sinusitis and, in COPD, oral thrush.

It contains one. Budesonide is an inhaled corticosteroid that works locally in the airways at doses far below steroid pills. Formoterol, the other ingredient, is a bronchodilator, not a steroid. Rinsing your mouth and spitting after each dose reduces thrush and hoarseness.

Both are ICS/LABA controllers. Symbicort (budesonide/formoterol) is a spray used as 2 puffs twice daily and starts working within about 15 minutes, which is why it can also be used as a reliever in SMART plans. Advair (fluticasone/salmeterol) is usually a dry-powder Diskus with 1 inhalation twice daily; salmeterol takes 30–60 minutes to act, so Advair can't be a reliever. Advair Diskus has much cheaper generics (Wixela), while Symbicort's generics are only modestly cheaper — but both brands offer $35 caps for eligible patients.

Yes, this is a common COPD combination: tiotropium (Spiriva), a long-acting muscarinic antagonist, added to an ICS/LABA like Symbicort is called "triple therapy." There are also single-inhaler triple products, such as Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) and Trelegy Ellipta. Your prescriber decides which combination fits.

Don't stop on your own. Stopping a controller suddenly can let asthma inflammation return within days to weeks and raise the risk of a serious flare-up. When asthma has been well controlled for about 3 months, your prescriber may step down gradually — for example from 160/4.5 to 80/4.5 — and monitor how you do.

Most Medicare Part D plans cover budesonide/formoterol in some form, often preferring a generic. Manufacturer copay caps don't apply to Medicare, but Part D caps your total 2026 out-of-pocket drug costs at $2,100 a year. We can check which version your plan covers best.

Yes — it's FDA-approved for asthma in children 6 and older at 2 puffs of 80/4.5 twice daily. Guidelines also use budesonide/formoterol SMART in children 4 and older (maximum 8 puffs a day). A spacer (valved holding chamber) helps children get the dose into their lungs. As with all inhaled steroids, pediatricians monitor growth and use the lowest effective dose.